ClinicalTrials.gg
Sign In

Hebei Senlang Biotechnology Inc., Ltd. clinical trials

Also known as SenlangBio.

The registry lists 40 studies whose lead sponsor is Hebei Senlang Biotechnology Inc., Ltd.. 15 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 27, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Get an email when these change. Save the Hebei Senlang Biotechnology Inc., Ltd. studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Pipeline: 5 programmes

Each counted once: 5 with a study Hebei Senlang Biotechnology Inc., Ltd. leads registered in the last two years.

  • Phase 1
  • Phase 2

The 5 programmes — sign in to see the list, free: with every programme, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Hebei Senlang Biotechnology Inc., Ltd.’s own registered studies; Hebei Senlang Biotechnology Inc., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programmes are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Hebei Senlang Biotechnology Inc., Ltd.’s studies test, most open studies first — 8 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

6 of Hebei Senlang Biotechnology Inc., Ltd.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. 1F
  5. 2M
  6. A
  7. M
  8. J
  9. J
  10. 1A
  11. 1S
  12. 1O
  13. N

All 6

Show 1 more

Add all 6 to your calendar (.ics) → With an account.

All 40 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1538%Recruiting 12 · Not yet recruiting 3
  • Completed25%
  • Status unknown or other2357%

Phase

  • Phase 112
  • Early Phase 18
  • Phase 26

Where

Over the years

  1. 16
  2. 17
  3. 18
  4. 19
  5. 1720
  6. 21
  7. 22
  8. 23
  9. 24
  10. 25
  11. 226

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Hebei Senlang Biotechnology Inc., Ltd..

  • Hebei Senlang Biotechnology Inc., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    40 studies

Studies

Recruiting first, then most recently updated. Showing 40 of 40.